MENU
MTD
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Mettler-Toledo International (MTD) Earnings Date & Reports

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries... Show more

A.I. Advisor
published Earnings

MTD is expected to report earnings to rise 22.90% to $10.95 per share on July 23

Mettler-Toledo International MTD Stock Earnings Reports
Q2'26
Est.
$10.95
Q1'26
Beat
by $0.20
Q4'25
Beat
by $0.56
Q3'25
Beat
by $0.49
Q2'25
Beat
by $0.49
The last earnings report on May 07 showed earnings per share of $8.91, beating the estimate of $8.71. With 186.34K shares outstanding, the current market capitalization sits at 21.67B.

Mettler-Toledo International Inc. (MTD) First Quarter 2026 Earnings Recap: Solid EPS Beat Amid Modest Growth

Key Takeaways

  • Mettler-Toledo reported Q1 2026 sales of $947.1 million, up 7% year-over-year on a reported basis and beating consensus estimates of approximately $943 million.
  • Adjusted EPS came in at $8.91, a 9% increase from $8.19 in the prior year and above analyst expectations of around $8.70-$8.75.
  • GAAP diluted EPS rose 7% to $8.33 from $7.81, with adjusted operating profit up 4% to $246.2 million (26.0% of sales).
  • Local currency sales grew 3%, or 1% excluding acquisitions, reflecting steady demand in precision instruments despite macro uncertainties.
  • Full-year 2026 guidance updated to 4% local currency sales growth and adjusted EPS of $46.30-$46.95, implying 8%-10% growth.
  • Shares edged lower post-earnings as investors weighed the beat against cautious Q2 guidance below consensus.

Earnings Context and Why It Matters

Mettler-Toledo International Inc. (MTD), a leading supplier of precision instruments for life sciences, industrial, and food sectors, released its fiscal first quarter 2026 results on May 7, 2026. This report is critical amid volatile markets, as investors assess resilience in lab and analytical equipment demand. Following a strong Q4 2025 where sales grew 8% and adjusted EPS hit $13.36, Q1 tests ongoing trends like automation and onshoring. With shares near $1,320, the results signal operational strength but highlight macro headwinds, influencing views on margins and growth in a high-interest-rate environment. For shareholders, execution on innovation and cost controls remains key to sustaining profitability.

Mettler-Toledo delivered Q1 2026 net sales of $947.1 million, surpassing consensus estimates of $943 million by 0.4% and up 7% from $883.7 million in Q1 2025 on a reported basis. In local currency terms, sales rose 3%, or 1% excluding acquisitions—flat in the Americas but up 3% in Asia/Rest of World. Regional reported growth was strongest in Europe (+12%) and Asia/Rest of World (+8%).

GAAP diluted EPS increased 7% to $8.33 from $7.81, while adjusted EPS (non-GAAP, excluding amortization, restructuring, and other items) climbed 9% to $8.91 from $8.19, exceeding expectations of $8.70-$8.75. This beat was driven by solid margin execution, with adjusted operating profit at $246.2 million (26.0% margin), up 4% despite a slight dip from 26.8% last year. Gross margin was 58.7%, down modestly from 59.5% due to mix and costs.

Earnings before taxes reached $209.7 million, up from $201.9 million. CEO Patrick Kaltenbach noted strong execution in an uncertain environment, crediting innovation investments. Guidance updates include Q2 local currency sales growth of ~3% and adjusted EPS of $10.70-$10.85 (below prior consensus ~$10.96); full-year local currency sales ~4% and adjusted EPS $46.30-$46.95 (slight raise from $46.05-$46.70).

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization (e.g., large-cap like MTD), technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, empowering data-driven decisions in dynamic markets like precision instruments. Explore it today to uncover potential opportunities tailored to your strategy.

Market Reaction and Investor Sentiment

Post-release on May 7, MTD shares declined about 0.5%-1.1% in after-hours trading, trading around $1,320 despite the EPS beat. Investors appeared cautious on modest organic growth (1% ex-acquisitions) and Q2 guidance implying adjusted EPS growth of 6%-8% below some consensus views (~$10.96). Sentiment reflects balanced execution amid macro uncertainty, with prior quarters showing beats but mixed reactions tied to guidance. Broader healthcare equipment sector stability supported resilience, though tariff and inflation concerns lingered.

Forward Outlook and Key Factors to Monitor

Mettler-Toledo's updated FY 2026 guidance projects ~4% local currency sales growth, unchanged from prior views, with adjusted EPS of $46.30-$46.95 signaling 8%-10% expansion. This reflects confidence in core markets despite headwinds.

Q2 guidance flags ~3% local currency sales growth and adjusted EPS of $10.70-$10.85. Investors should watch regional dynamics: Americas stability, Europe's currency impacts, and Asia's onshoring tailwinds. Government grants ($6.2 million in Q1, more expected) bolster automation investments.

Key monitors include operating margins (targeted +60-70 bps ex-FX annually), free cash flow (~$900 million projected), and share repurchases ($825-$875 million). Restructuring ($7.3 million in Q1) and amortization trends merit attention. Broader factors: tariffs, inflation on costs, and demand for precision tools in life sciences and food safety. Upcoming catalysts: Q2 results and macro updates on trade/geopolitics.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

View a ticker or compare two or three
MTD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of precision instruments

Industry MedicalSpecialties

Profile
Details
Industry
Medical Specialties
Address
1900 Polaris Parkway
Phone
+1 614 438-4511
Employees
17300
Web
https://www.mt.com